vimarsana.com

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Taiwan ,United States ,Hong Kong ,Stockholm ,Sweden ,Macau ,China ,Japan ,Germany ,Uptal Patel ,Morgan Warners ,Caroline Fry ,Clinical Research ,European Renal Association ,Linkedin ,Aachen University ,Human Immunology Biosciences Inc ,Immunology Biosciences ,Study Investigator ,Chief Medical Officer ,Monograph Capital ,Alpha Wave Global ,Arkin Bio Capital ,Jeito Capital ,Viking Global ,Life Expectancy ,Patients From ,Southeastern United States With Iga ,

vimarsana.com © 2020. All Rights Reserved.